Literature DB >> 15322954

EINAQ -- a European educational initiative on Attention-Deficit Hyperactivity Disorder and associated problems.

Aribert Rothenberger1, Marina Danckaerts, Manfred Döpfner, Joseph Sergeant, Hans-Christoph Steinhausen.   

Abstract

BACKGROUND: Continuing Medical Education (CME) plays an important role in quality management, especially as quality assurance, for the improvement of healthcare in child and adolescent psychiatry. This requires responsibility regarding quality standards of clinical practice throughout Europe as outlined by the European Union of Medical Specialists (UEMS).
OBJECTIVE: Therefore, steps should be undertaken to improve specialists' medical care and harmonize it in Europe. Attention-Deficit Hyperactivity Disorder (ADHD) with its many co-existing developmental disorders/problems is the central healthcare problem in child and adolescent psychiatry with high impact on society. Therefore, it was chosen as the target.
METHOD: A European Interdisciplinary Network for ADHD Quality Assurance (EINAQ) was founded, didactic material was developed and a faculty of experts from several European countries established to offer all over Europe harmonized courses on ADHD and associated problems.
RESULTS: Pilot courses were given in Germany in 2003/2004 and were highly appreciated by the participants. Further courses in Germany and other European countries will take place in 2004.
CONCLUSION: EINAQ seems to be on the right track to be part of CME and specialized networks for healthcare in ADHD to improve the provision for mental health problems in children and adolescents in Europe. Cooperative projects with official European bodies like the UEMS -- Section on Child and Adolescent Psychiatry/Psychotherapy and the European Society of Child and Adolescent Psychiatry could strengthen the impact of EINAQ.

Entities:  

Mesh:

Year:  2004        PMID: 15322954     DOI: 10.1007/s00787-004-1003-9

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  4 in total

1.  The training logbook of UEMS section/board on child and adolescent psychiatry (CAPP) progress concerning European harmonization.

Authors:  A Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2001-09       Impact factor: 4.785

2.  Clinical guidelines for hyperkinetic disorder. European Society for Child and Adolescent Psychiatry.

Authors:  E Taylor; J Sergeant; M Doepfner; B Gunning; S Overmeyer; H J Möbius; H G Eisert
Journal:  Eur Child Adolesc Psychiatry       Date:  1998-12       Impact factor: 4.785

Review 3.  Co-existing disorders in ADHD -- implications for diagnosis and intervention.

Authors:  Christopher Gillberg; I Carina Gillberg; Peder Rasmussen; Björn Kadesjö; Henrik Söderström; Mania Råstam; Mato Johnson; Aribert Rothenberger; Lena Niklasson
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

4.  European clinical guidelines for hyperkinetic disorder -- first upgrade.

Authors:  Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

  4 in total
  8 in total

1.  Child and adolescent psychiatry training in Europe: differences and challenges in harmonization.

Authors:  Koray Karabekiroglu; Burak Doğangün; Sabri Hergüner; Thomas von Salis; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-11-27       Impact factor: 4.785

2.  Psychopathological screening of children with ADHD: Strengths and Difficulties Questionnaire in a pan-European study.

Authors:  Andreas Becker; Hans-Christoph Steinhausen; Gisli Baldursson; Sören Dalsgaard; Maria J Lorenzo; Stephen J Ralston; Manfred Döpfner; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 4.785

3.  Factors related to health-related quality of life (HRQoL) among children with ADHD in Europe at entry into treatment.

Authors:  Anne W Riley; Georg Spiel; David Coghill; Manfred Döpfner; Bruno Falissard; Maria J Lorenzo; Ulrich Preuss; Stephen J Ralston
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-12       Impact factor: 4.785

4.  Can we--and should we--have a Europsychiatry for Children and Adolescents? The work of the UEMS Section and Board for Child and Adolescent Psychiatry/Psychotherapy.

Authors:  Peter Hill; Aribert Rothenberger
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-12       Impact factor: 4.785

Review 5.  Managing attention deficit/hyperactivity disorder: unmet needs and future directions.

Authors:  C R Steer
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

6.  Influence of methylphenidate on brain development--an update of recent animal experiments.

Authors:  Thorsten Grund; Konrad Lehmann; Nathalie Bock; Aribert Rothenberger; Gertraud Teuchert-Noodt
Journal:  Behav Brain Funct       Date:  2006-01-10       Impact factor: 3.759

7.  Serum level of semicarbazide-sensitive amine oxidase in children with ADHD.

Authors:  Veit Roessner; Henrik Uebel; Andreas Becker; Georg Beck; Stefan Bleich; Aribert Rothenberger
Journal:  Behav Brain Funct       Date:  2006-01-27       Impact factor: 3.759

8.  Environmental enrichment has no effect on the development of dopaminergic and GABAergic fibers during methylphenidate treatment of early traumatized gerbils.

Authors:  Susanne Brummelte; Thorsten Grund; Gunther H Moll; Gertraud Teuchert-Noodt; Ralph R Dawirs
Journal:  J Negat Results Biomed       Date:  2008-05-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.